North Mississippi Health Services (NMHS) partnered with On Demand Pharmaceuticals to address persistent drug shortages by producing essential medications on-site. Utilizing ODP's Shortage Response Pharmacy on Demand™ (PoD), NMHS produced lidocaine—a critical anesthetic that had been in short supply ...
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system 来自 国家科技图书文献中心 喜欢 0 阅读量: 573 作者:A Adamo,RL Beingessner,M Behnam,J Chen,TF Jamison,KF Jensen,Monbaliu, Jean-Christophe M.,AS Myerson,EM Revalor,DR Snead ...
The article reports that pharmaceuticals company Locus Inc. is to use on-demand supercomputing from IBM to help speed up research into drugs to fight HIV and Aids. The U.S. company will use a remote connection into IBM supercomputing resources in New York, where it will run complex ...
Teach forecastingSAS®OnDemand for Academics: Forecast Server Getting Started To get started with SAS OnDemand for Academics: Studio, just send the link to your students. It's that easy; the software isn't gated, so they can start using it right away. ...
we provide proof-of-concept for an innovative strategy for on-demand contraception, where a man would take a birth control pill shortly before sex, only as needed. Soluble adenylyl cyclase (sAC) is essential for sperm motility and maturation. We show a single dose of a safe, acutely-acting...
15, 2017-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has lifted the hold on clinical studies with fitusiran, ...
"The new production lines of the prescription drug production capacities of our Beijing pharmaceuticals product supply center are set to become operational in the middle of next year. This will increase the annual output of the Beijing...
1 Development collaboration with Cellenkos, Inc. 2 Clinical development of axatilimab in GVHD conducted in collaboration with Syndax Pharmaceuticals. Other Hematology/Oncology – key highlights Oral PD-L1: In November, data from Incyte's oral, small molecule PD-L1 program, including P...
Rhythm Pharmaceuticals RYTM announced that the FDA approved its supplemental New Drug Application (sNDA), seeking the label expansion of its genetic obesity drug, Imcivree, to include patients with Bardet-Biedl syndrome (BBS), a rare genetic disease of o
The pharmaceuticals market was the largest segment of the biotechnology services market segmented by application, accounting for 40.0% of the total in 2020. Going forward, the academic market is expected to be the fastest growing segment in the biotechnology services market segmented by area of ...